Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 130 Carboplatin 106 Paclitaxel 65 Cisplatin 61 Gemcitabine 59 Pemetrexed 57 Bevacizumab 54 Docetaxel 49 Fluorouracil 43 Oxaliplatin 41 atezolizumab 37 Dexamethasone 36 Leucovorin 34 Cetuximab 33 130-nm albumin-bound paclitaxel 33 Nivolumab 30 Cyclophosphamide 30 Prednisone 29 Rituximab 28 Capecitabine 28 durvalumab 27 Fulvestrant 24 Lenalidomide 22 enzalutamide 21 Letrozole 21 Irinotecan 21 venetoclax 20 Doxorubicin 19 ribociclib 18 pomalidomide 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Biopsy, Large-Core Needle × 30 days × Clear all

NCT03524430 2026-05-28

BREVITY

Rna Diagnostics Inc.

Phase NA Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡